U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

2006
190
Substance Class Protein
Created
by admin
on Mon Mar 31 21:08:40 GMT 2025
Edited
by admin
on Mon Mar 31 21:08:40 GMT 2025
Protein Sub Type
Sequence Type COMPLETE
Record UNII
DTI67O9503
Record Status Validated (UNII)
Record Version
  • Download
Related Record Type
Name Type Language
ALGLUCOSIDASE ALFA
DASH   EMA EPAR   INN   MART.   USAN   VANDF   WHO-DD  
USAN   INN  
Official Name English
ACID .ALPHA.-GLUCOSIDASE
MI  
Preferred Name English
LUMIZYME
Brand Name English
RHGAA
Code English
ALGLUCOSIDASE ALFA [VANDF]
Common Name English
ALPHA-GLUCOSIDASE
Common Name English
ALGLUCOSIDASE ALFA (GENETICAL RECOMBINATION) [JAN]
Common Name English
alglucosidase alfa [INN]
Common Name English
MYOZYME
Brand Name English
ALGLUCOSIDASE ALFA [PURPLE BOOK CDER]
Common Name English
ALGLUCOSIDASE ALFA [USAN]
Common Name English
Alglucosidase alfa [WHO-DD]
Common Name English
GZ419829
Code English
ACID .ALPHA.-GLUCOSIDASE [MI]
Common Name English
Acid alpha glucosidase [WHO-DD]
Common Name English
GLUCOSIDASE, PREPRO-.ALPHA.-(199-ARGININE,223-HISTIDINE) (HUMAN)
Common Name English
ALGLUCOSIDASE ALFA (GENETICAL RECOMBINATION)
JAN  
Common Name English
[199-Arginine,223-histidine]prepro-?-glucosidase (human)
Common Name English
ALGLUCOSIDASE ALFA [MART.]
Common Name English
ALGLUCOSIDASE ALFA [JAN]
Common Name English
ALGLUCOSIDASE [VANDF]
Common Name English
ALGLUCOSIDASE ALFA [EMA EPAR]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29726
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
FDA ORPHAN DRUG 100496
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
FDA ORPHAN DRUG 106597
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
EMA ASSESSMENT REPORTS MYOZYME (AUTHORIZED: GLYCOGEN STORAGE DISEASE TYPE II)
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
WHO-ATC A16AB07
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
NDF-RT N0000167711
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
WHO-VATC QA16AB07
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
NDF-RT N0000175821
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
Code System Code Type Description
DAILYMED
DTI67O9503
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
CAS
420784-05-0
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
INN
8475
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
WIKIPEDIA
ALGLUCOSIDASE ALFA
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
USAN
PP-47
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
ChEMBL
CHEMBL1201824
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
MERCK INDEX
m1370
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY Merck Index
EVMPD
SUB32952
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
RXCUI
629565
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY RxNorm
NCI_THESAURUS
C65221
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
EVMPD
SUB21275
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
DRUG BANK
DB01272
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
DRUG CENTRAL
5030
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
LACTMED
Alglucosidase Alfa
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
FDA UNII
DTI67O9503
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
JAPANESE REVIEW
MYOZYME
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY APPROVED APRIL 2007
SMS_ID
100000089564
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
IUPHAR
7561
Created by admin on Mon Mar 31 21:08:40 GMT 2025 , Edited by admin on Mon Mar 31 21:08:40 GMT 2025
PRIMARY
From To
1_882 1_896
1_591 1_602
1_477 1_502
1_47 1_71
1_36 1_52
1_26 1_53
Glycosylation Type MAMMALIAN
Glycosylation Link Type Site
N 1_84
N 1_177
N 1_334
N 1_414
N 1_596
N 1_826
N 1_869
Related Record Type Details
.ALPHA.-GLUCOSIDASE
SUB_CONCEPT->SUBSTANCE
LYSOSOMAL ALPHA-GLUCOSIDASE
TARGET->ENZYME REPLACEMENT
Structure of Duvoglustat
INHIBITOR -> TARGET
Related Record Type Details
ALGLUCOSIDASE ALFA
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
MOL_WEIGHT:NUMBER(CALCULATED) CHEMICAL
Molecular Formula CHEMICAL
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966